ARDD 2020: from aging mechanisms to interventions - PubMed (original) (raw)

Review

. 2020 Dec 30;12(24):24484-24503.

doi: 10.18632/aging.202454. Epub 2020 Dec 30.

Kotb Abdelmohsen 2, Pénélope Andreux 3, Ieva Bagdonaite 4, Nir Barzilai 5 6, Søren Brunak 7, Filipe Cabreiro 8, Rafael de Cabo 9, Judith Campisi 10, Ana Maria Cuervo 11, Marco Demaria 12, Collin Y Ewald 13, Evandro Fei Fang 14, Richard Faragher 15, Luigi Ferrucci 16, Adam Freund 17, Carlos G Silva-García 18, Anastasia Georgievskaya 19, Vadim N Gladyshev 20, David J Glass 21, Vera Gorbunova 22, Aubrey de Grey 23, Wei-Wu He 24, Jan Hoeijmakers 25, Eva Hoffmann 26, Steve Horvath 27, Riekelt H Houtkooper 28, Majken K Jensen 29, Martin Borch Jensen 30, Alice Kane 31, Moustapha Kassem 32, Peter de Keizer 33, Brian Kennedy 10 34 35, Gerard Karsenty 36, Dudley W Lamming 37, Kai-Fu Lee 38, Nanna MacAulay 39, Polina Mamoshina 40, Jim Mellon 41, Marte Molenaars 28, Alexey Moskalev 42, Andreas Mund 7, Laura Niedernhofer 43, Brenna Osborne 1, Heidi H Pak 37, Andrey Parkhitko 44, Nuno Raimundo 45, Thomas A Rando 46, Lene Juel Rasmussen 1, Carolina Reis 47, Christian G Riedel 48, Anais Franco-Romero 49, Björn Schumacher 50, David A Sinclair 31 51, Yousin Suh 52, Pam R Taub 53, Debra Toiber 54, Jonas T Treebak 55, Dario Riccardo Valenzano 56, Eric Verdin 10, Jan Vijg 5, Sergey Young 57, Lei Zhang 43, Daniela Bakula 1, Alex Zhavoronkov 58, Morten Scheibye-Knudsen 1

Affiliations

Review

ARDD 2020: from aging mechanisms to interventions

Garik V Mkrtchyan et al. Aging (Albany NY). 2020.

Abstract

Aging is emerging as a druggable target with growing interest from academia, industry and investors. New technologies such as artificial intelligence and advanced screening techniques, as well as a strong influence from the industry sector may lead to novel discoveries to treat age-related diseases. The present review summarizes presentations from the 7th Annual Aging Research and Drug Discovery (ARDD) meeting, held online on the 1st to 4th of September 2020. The meeting covered topics related to new methodologies to study aging, knowledge about basic mechanisms of longevity, latest interventional strategies to target the aging process as well as discussions about the impact of aging research on society and economy. More than 2000 participants and 65 speakers joined the meeting and we already look forward to an even larger meeting next year. Please mark your calendars for the 8th ARDD meeting that is scheduled for the 31st of August to 3rd of September, 2021, at Columbia University, USA.

Keywords: aging; artificial intelligence; drug discovery; interventions.

PubMed Disclaimer

Conflict of interest statement

CONFLICTS OF INTEREST: E.F.F. has CRADA arrangements with ChromaDex, is a consultant to Aladdin Healthcare Technologies and the Vancouver Dementia Prevention Centre. M.S.K. is a consultant for Deep Longevity, AscentaTrio Health, Molecule, Novo Nordisk and the Longevity Vision Fund. M.S.K. is the owner of Soosys.com, Forsoegsperson.dk and a co-founder of Tracked.bio. D.A.S. is a consultant to, inventor of patents licensed to, board member of and equity owner of Iduna Therapeutics, a Life Biosciences company developing epigenetic reprograming therapies. D.A.S. is an advisor to Zymo Research, an epigenetics tools company. Additional disclosures are at https://genetics.med.harvard.edu/sinclair/people/sinclair-other.php.

Figures

Figure 1

Figure 1

Statistics from ARDD2020.

References

    1. Osborne B, Bakula D, Ben Ezra M, Dresen C, Hartmann E, Kristensen SM, Mkrtchyan GV, Nielsen MH, Petr MA, Scheibye-Knudsen M. New methodologies in ageing research. Ageing Res Rev. 2020; 62:101094. 10.1016/j.arr.2020.101094 -DOI -PubMed
    1. Coscia F, Doll S, Bech JM, Schweizer L, Mund A, Lengyel E, Lindebjerg J, Madsen GI, Moreira JM, Mann M. A streamlined mass spectrometry-based proteomics workflow for large-scale FFPE tissue analysis. J Pathol. 2020; 251:100–12. 10.1002/path.5420 -DOI -PubMed
    1. Bagdonaite I, Pallesen EM, Ye Z, Vakhrushev SY, Marinova IN, Nielsen MI, Kramer SH, Pedersen SF, Joshi HJ, Bennett EP, Dabelsteen S, Wandall HH. O-glycan initiation directs distinct biological pathways and controls epithelial differentiation. EMBO Rep. 2020; 21:e48885. 10.15252/embr.201948885 -DOI -PMC -PubMed
    1. Janssens GE, Lin XX, Millan-Ariño L, Kavšek A, Sen I, Seinstra RI, Stroustrup N, Nollen EA, Riedel CG. Transcriptomics-based screening identifies pharmacological inhibition of Hsp90 as a means to defer aging. Cell Rep. 2019; 27:467–80.e6. 10.1016/j.celrep.2019.03.044 -DOI -PMC -PubMed
    1. Ma S, Yim SH, Lee SG, Kim EB, Lee SR, Chang KT, Buffenstein R, Lewis KN, Park TJ, Miller RA, Clish CB, Gladyshev VN. Organization of the mammalian metabolome according to organ function, lineage specialization, and longevity. Cell Metab. 2015; 22:332–43. 10.1016/j.cmet.2015.07.005 -DOI -PMC -PubMed

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources